Cargando…

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer

BACKGROUND: The treatment of luminal metastatic breast cancer is based on endocrine therapy and chemotherapy treatment is limited to the progression of this treatment. MATERIALS & METHODS: We analyzed the efficacy of treatment with bevacizumab plus paclitaxel in 43 patients with hormone receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Murillo, Serafin Morales, Cudos, Ariadna Gasol, Rodriguez, Joel Veas, Morales, Carles Canosa, Olivé, Jordi Melé, Villellas, Felip Vilardell, Sanchez Guzman, Douglas Rene, Martínez, Edelmiro Iglesias, Salvia, Antonieta Salud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849928/
https://www.ncbi.nlm.nih.gov/pubmed/33552547
http://dx.doi.org/10.2144/fsoa-2020-0146